BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Anderson N, Borlak J. Drug-induced phospholipidosis. FEBS Lett 2006;580:5533-40. [PMID: 16979167 DOI: 10.1016/j.febslet.2006.08.061] [Cited by in Crossref: 214] [Cited by in F6Publishing: 196] [Article Influence: 13.4] [Reference Citation Analysis]
Number Citing Articles
1 Thouvenin G, Nathan N, Epaud R, Clement A. Diffuse parenchymal lung disease caused by surfactant deficiency: dramatic improvement by azithromycin. BMJ Case Rep 2013;2013:bcr2013009988. [PMID: 23814005 DOI: 10.1136/bcr-2013-009988] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
2 Bhandari N, Figueroa DJ, Lawrence JW, Gerhold DL. Phospholipidosis Assay in HepG2 Cells and Rat or Rhesus Hepatocytes Using Phospholipid Probe NBD-PE. ASSAY and Drug Development Technologies 2008;6:407-19. [DOI: 10.1089/adt.2007.119] [Cited by in Crossref: 33] [Cited by in F6Publishing: 25] [Article Influence: 2.4] [Reference Citation Analysis]
3 Arnott JA, Planey SL. The influence of lipophilicity in drug discovery and design. Expert Opinion on Drug Discovery 2012;7:863-75. [DOI: 10.1517/17460441.2012.714363] [Cited by in Crossref: 278] [Cited by in F6Publishing: 229] [Article Influence: 27.8] [Reference Citation Analysis]
4 Rabia M, Leuzy V, Soulage C, Durand A, Fourmaux B, Errazuriz-Cerda E, Köffel R, Draeger A, Colosetti P, Jalabert A, Di Filippo M, Villard-Garon A, Bergerot C, Luquain-Costaz C, Moulin P, Rome S, Delton I, Hullin-Matsuda F. Bis(monoacylglycero)phosphate, a new lipid signature of endosome-derived extracellular vesicles. Biochimie 2020;178:26-38. [PMID: 32659447 DOI: 10.1016/j.biochi.2020.07.005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
5 Tengstrand EA, Miwa GT, Hsieh FY. Bis(monoacylglycerol)phosphate as a non-invasive biomarker to monitor the onset and time-course of phospholipidosis with drug-induced toxicities. Expert Opinion on Drug Metabolism & Toxicology 2010;6:555-70. [DOI: 10.1517/17425251003601961] [Cited by in Crossref: 40] [Cited by in F6Publishing: 32] [Article Influence: 3.3] [Reference Citation Analysis]
6 Takahashi K, Morita Y, Udagawa S, Yamakawa S, Watanabe D, Mutsuga M, Nakajima M, Kohno M, Miyamoto Y, Oshida K. Cytoplasmic Vacuolation and Tapetal Changes Induced by a Novel Analgesic Agent in Beagle Dogs. Toxicol Pathol 2019;47:494-503. [PMID: 30987541 DOI: 10.1177/0192623319836678] [Reference Citation Analysis]
7 Nath A, Sahu GK. Exploiting ensemble learning to improve prediction of phospholipidosis inducing potential. J Theor Biol 2019;479:37-47. [PMID: 31310757 DOI: 10.1016/j.jtbi.2019.07.009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
8 Kononenko V, Erman A, Petan T, Križaj I, Kralj S, Makovec D, Drobne D. Harmful at non-cytotoxic concentrations: SiO2-SPIONs affect surfactant metabolism and lamellar body biogenesis in A549 human alveolar epithelial cells. Nanotoxicology 2017;11:419-29. [PMID: 28406072 DOI: 10.1080/17435390.2017.1309704] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 3.4] [Reference Citation Analysis]
9 Klon AE. Machine learning algorithms for the prediction of hERG and CYP450 binding in drug development. Expert Opin Drug Metab Toxicol 2010;6:821-33. [PMID: 20465523 DOI: 10.1517/17425255.2010.489550] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
10 Kleiner DE. Histopathological Evaluation of Drug-Induced Liver Disease. Drug-Induced Liver Disease. Elsevier; 2013. pp. 241-63. [DOI: 10.1016/b978-0-12-387817-5.00015-7] [Cited by in Crossref: 3] [Article Influence: 0.3] [Reference Citation Analysis]
11 Song M, Kim Y, Ryu J. Phospholipidosis Induced by PPARγ Signaling in Human Bronchial Epithelial (BEAS-2B) Cells Exposed to Amiodarone. Toxicological Sciences 2011;120:98-108. [DOI: 10.1093/toxsci/kfq361] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
12 Fan H, Du X, Zhang J, Zheng H, Lu X, Wu Q, Li H, Wang H, Shi Y, Gao G, Zhou Z, Tan DX, Li X. Selective inhibition of Ebola entry with selective estrogen receptor modulators by disrupting the endolysosomal calcium. Sci Rep 2017;7:41226. [PMID: 28117364 DOI: 10.1038/srep41226] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 5.8] [Reference Citation Analysis]
13 Dheda K, Cox H, Esmail A, Wasserman S, Chang KC, Lange C. Recent controversies about MDR and XDR-TB: Global implementation of the WHO shorter MDR-TB regimen and bedaquiline for all with MDR-TB? Respirology 2018;23:36-45. [PMID: 28850767 DOI: 10.1111/resp.13143] [Cited by in Crossref: 41] [Cited by in F6Publishing: 33] [Article Influence: 8.2] [Reference Citation Analysis]
14 Ferreira PG, Costa S, Dias N, Ferreira AJ, Franco F. Simultaneous interstitial pneumonitis and cardiomyopathy induced by venlafaxine. J Bras Pneumol 2014;40:313-8. [PMID: 25029655 DOI: 10.1590/s1806-37132014000300015] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 1.4] [Reference Citation Analysis]
15 Hullin-matsuda F, Taguchi T, Greimel P, Kobayashi T. Lipid compartmentalization in the endosome system. Seminars in Cell & Developmental Biology 2014;31:48-56. [DOI: 10.1016/j.semcdb.2014.04.010] [Cited by in Crossref: 48] [Cited by in F6Publishing: 45] [Article Influence: 6.0] [Reference Citation Analysis]
16 Fischer CD, Duquette SC, Renaux BS, Feener TD, Morck DW, Hollenberg MD, Lucas MJ, Buret AG. Tulathromycin exerts proresolving effects in bovine neutrophils by inhibiting phospholipases and altering leukotriene B4, prostaglandin E2, and lipoxin A4 production. Antimicrob Agents Chemother 2014;58:4298-307. [PMID: 24820086 DOI: 10.1128/AAC.02813-14] [Cited by in Crossref: 10] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
17 Geng J, Aioub M, El-sayed MA, Barry BA. UV Resonance Raman Study of Apoptosis, Platinum-Based Drugs, and Human Cell Lines. ChemPhysChem 2018;19:1428-31. [DOI: 10.1002/cphc.201800252] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
18 Fakhravar Z, Ebrahimnejad P, Daraee H, Akbarzadeh A. Nanoliposomes: Synthesis methods and applications in cosmetics. Journal of Cosmetic and Laser Therapy 2016;18:174-81. [DOI: 10.3109/14764172.2015.1039040] [Cited by in Crossref: 27] [Cited by in F6Publishing: 16] [Article Influence: 4.5] [Reference Citation Analysis]
19 Solorio-Rodríguez A, Escamilla-Rivera V, Uribe-Ramírez M, González-Pozos S, Hernández-Soto J, Rafael-Vázquez L, De Vizcaya-Ruiz A. In vitro cytotoxicity study of superparamagnetic iron oxide and silica nanoparticles on pneumocyte organelles. Toxicol In Vitro 2021;72:105071. [PMID: 33352256 DOI: 10.1016/j.tiv.2020.105071] [Reference Citation Analysis]
20 Baell JB. Screening-based translation of public research encounters painful problems. ACS Med Chem Lett 2015;6:229-34. [PMID: 25941544 DOI: 10.1021/acsmedchemlett.5b00032] [Cited by in Crossref: 46] [Cited by in F6Publishing: 44] [Article Influence: 6.6] [Reference Citation Analysis]
21 Schlecht U, St Onge RP, Walther T, François JM, Davis RW. Cationic amphiphilic drugs are potent inhibitors of yeast sporulation. PLoS One 2012;7:e42853. [PMID: 22905177 DOI: 10.1371/journal.pone.0042853] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
22 Sun H, Shahane S, Xia M, Austin CP, Huang R. Structure based model for the prediction of phospholipidosis induction potential of small molecules. J Chem Inf Model 2012;52:1798-805. [PMID: 22725677 DOI: 10.1021/ci3001875] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
23 Natale A, Boeckmans J, Desmae T, De Boe V, De Kock J, Vanhaecke T, Rogiers V, Rodrigues RM. Hepatic cells derived from human skin progenitors show a typical phospholipidotic response upon exposure to amiodarone. Toxicology Letters 2018;284:184-94. [DOI: 10.1016/j.toxlet.2017.11.014] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
24 Yatsynovich Y, Souza D, Maroz N. Oxymorphone Hydrochloride Extended-Release (OPANA®) Associated With Acute Kidney Injury in a Chronic Pain Patient: A Case Report. A & A Case Reports 2017;9:324-7. [DOI: 10.1213/xaa.0000000000000607] [Cited by in Crossref: 2] [Article Influence: 0.4] [Reference Citation Analysis]
25 Meanwell NA. Improving Drug Candidates by Design: A Focus on Physicochemical Properties As a Means of Improving Compound Disposition and Safety. Chem Res Toxicol 2011;24:1420-56. [DOI: 10.1021/tx200211v] [Cited by in Crossref: 325] [Cited by in F6Publishing: 290] [Article Influence: 29.5] [Reference Citation Analysis]
26 Louie AK, Jones HN. Case Report: Retinal Toxicity Secondary to Ritonavir. Optom Vis Sci 2019;96:376-81. [PMID: 31046022 DOI: 10.1097/OPX.0000000000001368] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 4.5] [Reference Citation Analysis]
27 Ostaszewska T, Śliwiński J, Kamaszewski M, Sysa P, Chojnacki M. Cytotoxicity of silver and copper nanoparticles on rainbow trout (Oncorhynchus mykiss) hepatocytes. Environ Sci Pollut Res Int 2018;25:908-15. [PMID: 29071536 DOI: 10.1007/s11356-017-0494-0] [Cited by in Crossref: 34] [Cited by in F6Publishing: 27] [Article Influence: 6.8] [Reference Citation Analysis]
28 Pedro L, Rudewicz PJ. Analysis of Live Single Cells by Confocal Microscopy and High-Resolution Mass Spectrometry to Study Drug Uptake, Metabolism, and Drug-Induced Phospholipidosis. Anal Chem 2020;92:16005-15. [PMID: 33280372 DOI: 10.1021/acs.analchem.0c03534] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
29 Sahini N, Selvaraj S, Borlak J. Whole genome transcript profiling of drug induced steatosis in rats reveals a gene signature predictive of outcome. PLoS One 2014;9:e114085. [PMID: 25470483 DOI: 10.1371/journal.pone.0114085] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 3.6] [Reference Citation Analysis]
30 Meanwell NA. Improving Drug Design: An Update on Recent Applications of Efficiency Metrics, Strategies for Replacing Problematic Elements, and Compounds in Nontraditional Drug Space. Chem Res Toxicol 2016;29:564-616. [DOI: 10.1021/acs.chemrestox.6b00043] [Cited by in Crossref: 102] [Cited by in F6Publishing: 84] [Article Influence: 17.0] [Reference Citation Analysis]
31 Jiang JK, McCoy JG, Shen M, LeClair CA, Huang W, Negri A, Li J, Blue R, Harrington AW, Naini S, David G 3rd, Choi WS, Volpi E, Fernandez J, Babayeva M, Nedelman MA, Filizola M, Coller BS, Thomas CJ. A novel class of ion displacement ligands as antagonists of the αIIbβ3 receptor that limit conformational reorganization of the receptor. Bioorg Med Chem Lett 2014;24:1148-53. [PMID: 24461295 DOI: 10.1016/j.bmcl.2013.12.122] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
32 Grandl M, Schmitz G. Fluorescent high-content imaging allows the discrimination and quantitation of E-LDL-induced lipid droplets and Ox-LDL-generated phospholipidosis in human macrophages. Cytometry A 2010;77:231-42. [PMID: 20014301 DOI: 10.1002/cyto.a.20828] [Cited by in Crossref: 4] [Cited by in F6Publishing: 20] [Article Influence: 0.3] [Reference Citation Analysis]
33 Almansour M, Sajti L, Melhim W, Jarrar BM. Ultrastructural hepatocytic alterations induced by silver nanoparticle toxicity. Ultrastruct Pathol 2016;40:92-100. [PMID: 26934218 DOI: 10.3109/01913123.2016.1150377] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 2.5] [Reference Citation Analysis]
34 Bardoliwala D, Javia A, Ghosh S, Misra A, Sawant K. Formulation and clinical perspectives of inhalation-based nanocarrier delivery: a new archetype in lung cancer treatment. Ther Deliv 2021;12:397-418. [PMID: 33902294 DOI: 10.4155/tde-2020-0101] [Reference Citation Analysis]
35 Sun H, Xia M, Shahane SA, Jadhav A, Austin CP, Huang R. Are hERG channel blockers also phospholipidosis inducers? Bioorg Med Chem Lett 2013;23:4587-90. [PMID: 23856051 DOI: 10.1016/j.bmcl.2013.06.034] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 2.8] [Reference Citation Analysis]
36 Ruangchira-urai R, Colby TV, Klein J, Nielsen GP, Kradin RL, Mark EJ. Nodular Amiodarone Lung Disease. American Journal of Surgical Pathology 2008;32:1654-60. [DOI: 10.1097/pas.0b013e31816d1cbc] [Cited by in Crossref: 13] [Cited by in F6Publishing: 3] [Article Influence: 0.9] [Reference Citation Analysis]
37 Broeders JJ, Parmentier C, Truisi GL, Jossé R, Alexandre E, Savary CC, Hewitt PG, Mueller SO, Guillouzo A, Richert L, van Eijkeren JC, Hermens JL, Blaauboer BJ. Biokinetics of chlorpromazine in primary rat and human hepatocytes and human HepaRG cells after repeated exposure. Toxicology in Vitro 2015;30:52-61. [DOI: 10.1016/j.tiv.2014.08.012] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
38 Casartelli A, Lanzoni A, Comelli R, Crivellente F, Defazio R, Dorigatti R, Fasdelli N, Faustinelli I, Pagliarusco S, Tontodonati M, Cristofori P. A novel and integrated approach for the identification and characterization of drug-induced cardiac toxicity in the dog. Toxicol Pathol 2011;39:361-71. [PMID: 21422262 DOI: 10.1177/0192623310390704] [Cited by in Crossref: 25] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
39 Cepeda SS, Williams DE, Grant KB. Evaluating metal ion salts as acid hydrolase mimics: metal-assisted hydrolysis of phospholipids at lysosomal pH. Biometals 2012;25:1207-19. [DOI: 10.1007/s10534-012-9583-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
40 Petibone DM, Majeed W, Casciano DA. Autophagy function and its relationship to pathology, clinical applications, drug metabolism and toxicity. J Appl Toxicol 2017;37:23-37. [PMID: 27682190 DOI: 10.1002/jat.3393] [Cited by in Crossref: 32] [Cited by in F6Publishing: 26] [Article Influence: 5.3] [Reference Citation Analysis]
41 Natalie M, Margino S, Erik H, Annelieke P, Geert V, Philippe V. A 96-well flow cytometric screening assay for detecting in vitro phospholipidosis-induction in the drug discovery phase. Toxicology in Vitro 2009;23:217-26. [DOI: 10.1016/j.tiv.2008.11.010] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 1.8] [Reference Citation Analysis]
42 Kleiner DE. Liver Injury Due to Drugs and Herbal Agents. Practical Hepatic Pathology: a Diagnostic Approach. Elsevier; 2018. pp. 327-70. [DOI: 10.1016/b978-0-323-42873-6.00023-8] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
43 Rampa KM, Van De Venter M, Koekemoer TC, Swanepoel B, Venables L, Hattingh AC, Viljoen AM, Kamatou GP. Exploring four South African Croton species for potential anti-inflammatory properties: in vitro activity and toxicity risk assessment. J Ethnopharmacol 2022;282:114596. [PMID: 34492319 DOI: 10.1016/j.jep.2021.114596] [Reference Citation Analysis]
44 Miyamoto S, Matsumoto A, Mori I, Horinouchi A. Relationship between in vitro phospholipidosis assay using HepG2 cells and 2-week toxicity studies in rats. Toxicol Mech Methods 2009;19:477-85. [PMID: 19793005 DOI: 10.1080/15376510903322834] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
45 Low JD, Bartberger MD, Cheng Y, Whittington D, Xue Q, Wood S, Allen JR, Minatti AE. Diastereoselective synthesis of fused cyclopropyl-3-amino-2,4-oxazine β-amyloid cleaving enzyme (BACE) inhibitors and their biological evaluation. Bioorganic & Medicinal Chemistry Letters 2018;28:1111-5. [DOI: 10.1016/j.bmcl.2018.01.056] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
46 Marcos AL, Corradi GR, Mazzitelli LR, Casali CI, Fernández Tome MDC, Adamo HP, de Tezanos Pinto F. The Parkinson-associated human P5B-ATPase ATP13A2 modifies lipid homeostasis. Biochim Biophys Acta Biomembr 2019;1861:182993. [PMID: 31132336 DOI: 10.1016/j.bbamem.2019.05.015] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
47 Alderson RG, De Ferrari L, Mavridis L, McDonagh JL, Mitchell JB, Nath N. Enzyme informatics. Curr Top Med Chem 2012;12:1911-23. [PMID: 23116471 DOI: 10.2174/156802612804547353] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
48 Broeders JJ, Hermens JL, Blaauboer BJ, Zurich M. The in vitro biokinetics of chlorpromazine and diazepam in aggregating rat brain cell cultures after repeated exposure. Toxicology in Vitro 2015;30:185-91. [DOI: 10.1016/j.tiv.2014.07.015] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
49 Showalter MR, Berg AL, Nagourney A, Heil H, Carraway KL 3rd, Fiehn O. The Emerging and Diverse Roles of Bis(monoacylglycero) Phosphate Lipids in Cellular Physiology and Disease. Int J Mol Sci 2020;21:E8067. [PMID: 33137979 DOI: 10.3390/ijms21218067] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
50 Schmitz G, Grandl M. Lipid homeostasis in macrophages – Implications for atherosclerosis. In: Amara S, Bamberg E, Fleischmann B, Gudermann T, Hebert S, Jahn R, Lederer W, Lill R, Miyajima A, Offermanns S, Zechner R, editors. Reviews of Physiology Biochemistry and Pharmacology. Berlin: Springer Berlin Heidelberg; 2008. pp. 93-125. [DOI: 10.1007/112_2008_802] [Cited by in Crossref: 43] [Cited by in F6Publishing: 41] [Article Influence: 3.1] [Reference Citation Analysis]
51 Vejux A, Malvitte L, Lizard G. Side effects of oxysterols: cytotoxicity, oxidation, inflammation, and phospholipidosis. Braz J Med Biol Res 2008;41:545-56. [DOI: 10.1590/s0100-879x2008000700001] [Cited by in Crossref: 116] [Cited by in F6Publishing: 33] [Article Influence: 8.3] [Reference Citation Analysis]
52 Zschocke J, Zimmermann N, Berning B, Ganal V, Holsboer F, Rein T. Antidepressant drugs diversely affect autophagy pathways in astrocytes and neurons--dissociation from cholesterol homeostasis. Neuropsychopharmacology 2011;36:1754-68. [PMID: 21508931 DOI: 10.1038/npp.2011.57] [Cited by in Crossref: 64] [Cited by in F6Publishing: 60] [Article Influence: 5.8] [Reference Citation Analysis]
53 Britt HM, García-Herrero CA, Denny PW, Mosely JA, Sanderson JM. Lytic reactions of drugs with lipid membranes. Chem Sci 2019;10:674-80. [PMID: 30774868 DOI: 10.1039/c8sc04831b] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
54 Rhein C, Löber S, Gmeiner P, Gulbins E, Tripal P, Kornhuber J. Derivatization of common antidepressant drugs increases inhibition of acid sphingomyelinase and reduces induction of phospholipidosis. J Neural Transm (Vienna) 2018;125:1837-45. [PMID: 30191367 DOI: 10.1007/s00702-018-1923-z] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
55 Kosol S, Schrank E, Krajačić MB, Wagner GE, Meyer NH, Göbl C, Rechberger GN, Zangger K, Novak P. Probing the Interactions of Macrolide Antibiotics with Membrane-Mimetics by NMR Spectroscopy. J Med Chem 2012;55:5632-6. [DOI: 10.1021/jm300647f] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 2.3] [Reference Citation Analysis]
56 Breher-Esch S, Sahini N, Trincone A, Wallstab C, Borlak J. Genomics of lipid-laden human hepatocyte cultures enables drug target screening for the treatment of non-alcoholic fatty liver disease. BMC Med Genomics 2018;11:111. [PMID: 30547786 DOI: 10.1186/s12920-018-0438-7] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
57 Weaver RJ, Blomme EA, Chadwick AE, Copple IM, Gerets HHJ, Goldring CE, Guillouzo A, Hewitt PG, Ingelman-sundberg M, Jensen KG, Juhila S, Klingmüller U, Labbe G, Liguori MJ, Lovatt CA, Morgan P, Naisbitt DJ, Pieters RHH, Snoeys J, van de Water B, Williams DP, Park BK. Managing the challenge of drug-induced liver injury: a roadmap for the development and deployment of preclinical predictive models. Nat Rev Drug Discov 2020;19:131-48. [DOI: 10.1038/s41573-019-0048-x] [Cited by in Crossref: 48] [Cited by in F6Publishing: 45] [Article Influence: 16.0] [Reference Citation Analysis]
58 Bugarski M, Ghazi S, Polesel M, Martins JR, Hall AM. Changes in NAD and Lipid Metabolism Drive Acidosis-Induced Acute Kidney Injury. J Am Soc Nephrol 2021;32:342-56. [PMID: 33478973 DOI: 10.1681/ASN.2020071003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
59 Jiang LL, Zhao DS, Fan YX, Yu Q, Lai YS, Li P, Li HJ. Transcriptome analysis to assess the cholestatic hepatotoxicity induced by Polygoni Multiflori Radix: Up-regulation of key enzymes of cholesterol and bile acid biosynthesis. J Proteomics 2018;177:40-7. [PMID: 29438852 DOI: 10.1016/j.jprot.2018.02.014] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
60 Robichaud JC, van der Veen JN, Yao Z, Trigatti B, Vance DE. Hepatic uptake and metabolism of phosphatidylcholine associated with high density lipoproteins. Biochim Biophys Acta 2009;1790:538-51. [PMID: 19250958 DOI: 10.1016/j.bbagen.2009.02.010] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 1.7] [Reference Citation Analysis]
61 Guillot L, Tabary O, Nathan N, Corvol H, Clement A. Macrolides: New therapeutic perspectives in lung diseases. The International Journal of Biochemistry & Cell Biology 2011;43:1241-6. [DOI: 10.1016/j.biocel.2011.05.009] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
62 Arbo MD, Melega S, Stöber R, Schug M, Rempel E, Rahnenführer J, Godoy P, Reif R, Cadenas C, de Lourdes Bastos M, Carmo H, Hengstler JG. Hepatotoxicity of piperazine designer drugs: up-regulation of key enzymes of cholesterol and lipid biosynthesis. Arch Toxicol 2016;90:3045-60. [DOI: 10.1007/s00204-016-1665-3] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 3.7] [Reference Citation Analysis]
63 Ikeda K, Hirayama M, Hirota Y, Asa E, Seki J, Tanaka Y. Drug-induced phospholipidosis is caused by blockade of mannose 6-phosphate receptor-mediated targeting of lysosomal enzymes. Biochemical and Biophysical Research Communications 2008;377:268-74. [DOI: 10.1016/j.bbrc.2008.09.121] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 2.6] [Reference Citation Analysis]
64 Satapathy SK, Kuwajima V, Nadelson J, Atiq O, Sanyal AJ. Drug-induced fatty liver disease: An overview of pathogenesis and management. Ann Hepatol 2015;14:789-806. [PMID: 26436351 DOI: 10.5604/16652681.1171749] [Cited by in Crossref: 35] [Cited by in F6Publishing: 26] [Article Influence: 5.8] [Reference Citation Analysis]
65 Petersen NH, Olsen OD, Groth-Pedersen L, Ellegaard AM, Bilgin M, Redmer S, Ostenfeld MS, Ulanet D, Dovmark TH, Lønborg A, Vindeløv SD, Hanahan D, Arenz C, Ejsing CS, Kirkegaard T, Rohde M, Nylandsted J, Jäättelä M. Transformation-associated changes in sphingolipid metabolism sensitize cells to lysosomal cell death induced by inhibitors of acid sphingomyelinase. Cancer Cell 2013;24:379-93. [PMID: 24029234 DOI: 10.1016/j.ccr.2013.08.003] [Cited by in Crossref: 195] [Cited by in F6Publishing: 190] [Article Influence: 21.7] [Reference Citation Analysis]
66 Kleiner DE. Drugs and Toxins. Macsween's Pathology of the Liver. Elsevier; 2018. pp. 673-779. [DOI: 10.1016/b978-0-7020-6697-9.00012-1] [Cited by in Crossref: 9] [Article Influence: 2.3] [Reference Citation Analysis]
67 Lévêque MF, Berry L, Yamaryo-Botté Y, Nguyen HM, Galera M, Botté CY, Besteiro S. TgPL2, a patatin-like phospholipase domain-containing protein, is involved in the maintenance of apicoplast lipids homeostasis in Toxoplasma. Mol Microbiol 2017;105:158-74. [PMID: 28419631 DOI: 10.1111/mmi.13694] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 2.2] [Reference Citation Analysis]
68 Malek MR, Ahmadian S, Dehpour AR, Ebrahim-Habibi A, Shafizadeh M, Kashani-Amin E. Investigating the role of endogenous opioid system in chloroquine-induced phospholipidosis in rat liver by morphological, biochemical and molecular modelling studies. Clin Exp Pharmacol Physiol 2020;47:1575-83. [PMID: 32367550 DOI: 10.1111/1440-1681.13332] [Reference Citation Analysis]
69 Kazmi F, Hensley T, Pope C, Funk RS, Loewen GJ, Buckley DB, Parkinson A. Lysosomal sequestration (trapping) of lipophilic amine (cationic amphiphilic) drugs in immortalized human hepatocytes (Fa2N-4 cells). Drug Metab Dispos 2013;41:897-905. [PMID: 23378628 DOI: 10.1124/dmd.112.050054] [Cited by in Crossref: 140] [Cited by in F6Publishing: 134] [Article Influence: 15.6] [Reference Citation Analysis]
70 Rainey MM, Korostyshevsky D, Lee S, Perlstein EO. The antidepressant sertraline targets intracellular vesiculogenic membranes in yeast. Genetics 2010;185:1221-33. [PMID: 20457874 DOI: 10.1534/genetics.110.117846] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 2.6] [Reference Citation Analysis]
71 Sagini K, Buratta S, Delo F, Pellegrino RM, Giovagnoli S, Urbanelli L, Emiliani C. Drug-Induced Lysosomal Impairment Is Associated with the Release of Extracellular Vesicles Carrying Autophagy Markers. Int J Mol Sci 2021;22:12922. [PMID: 34884727 DOI: 10.3390/ijms222312922] [Reference Citation Analysis]
72 Rajapakse K, Drobne D, Kastelec D, Kogej K, Makovec D, Gallampois C, Amelina H, Danielsson G, Fanedl L, Marinsek-Logar R, Cristobal S. Proteomic analyses of early response of unicellular eukaryotic microorganism Tetrahymena thermophila exposed to TiO₂ particles. Nanotoxicology 2016;10:542-56. [PMID: 26524663 DOI: 10.3109/17435390.2015.1091107] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
73 Low JD, Bartberger MD, Chen K, Cheng Y, Fielden MR, Gore V, Hickman D, Liu Q, Allen Sickmier E, Vargas HM, Werner J, White RD, Whittington DA, Wood S, Minatti AE. Development of 2-aminooxazoline 3-azaxanthene β-amyloid cleaving enzyme (BACE) inhibitors with improved selectivity against Cathepsin D. Medchemcomm 2017;8:1196-206. [PMID: 30108829 DOI: 10.1039/c7md00106a] [Cited by in Crossref: 12] [Cited by in F6Publishing: 1] [Article Influence: 2.4] [Reference Citation Analysis]
74 Tancini B, Buratta S, Sagini K, Costanzi E, Delo F, Urbanelli L, Emiliani C. Insight into the Role of Extracellular Vesicles in Lysosomal Storage Disorders. Genes (Basel) 2019;10:E510. [PMID: 31284546 DOI: 10.3390/genes10070510] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 7.7] [Reference Citation Analysis]
75 LeCureux L, Cheng CS, Herbst J, Reilly TP, Lehman-McKeeman L, Otieno M. Evaluation and validation of multiple cell lines and primary mouse macrophages to predict phospholipidosis potential. Toxicol In Vitro 2011;25:1934-43. [PMID: 21767630 DOI: 10.1016/j.tiv.2011.06.017] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
76 Hullin-matsuda F, Luquain-costaz C, Bouvier J, Delton-vandenbroucke I. Bis(monoacylglycero)phosphate, a peculiar phospholipid to control the fate of cholesterol: Implications in pathology. Prostaglandins, Leukotrienes and Essential Fatty Acids 2009;81:313-24. [DOI: 10.1016/j.plefa.2009.09.006] [Cited by in Crossref: 59] [Cited by in F6Publishing: 56] [Article Influence: 4.5] [Reference Citation Analysis]
77 Passarelli MK, Newman CF, Marshall PS, West A, Gilmore IS, Bunch J, Alexander MR, Dollery CT. Single-Cell Analysis: Visualizing Pharmaceutical and Metabolite Uptake in Cells with Label-Free 3D Mass Spectrometry Imaging. Anal Chem 2015;87:6696-702. [PMID: 26023862 DOI: 10.1021/acs.analchem.5b00842] [Cited by in Crossref: 103] [Cited by in F6Publishing: 88] [Article Influence: 14.7] [Reference Citation Analysis]
78 Morissette G, Ammoury A, Rusu D, Marguery MC, Lodge R, Poubelle PE, Marceau F. Intracellular sequestration of amiodarone: role of vacuolar ATPase and macroautophagic transition of the resulting vacuolar cytopathology. Br J Pharmacol 2009;157:1531-40. [PMID: 19594752 DOI: 10.1111/j.1476-5381.2009.00320.x] [Cited by in Crossref: 43] [Cited by in F6Publishing: 39] [Article Influence: 3.3] [Reference Citation Analysis]
79 Raizman MB, Hamrah P, Holland EJ, Kim T, Mah FS, Rapuano CJ, Ulrich RG. Drug-induced corneal epithelial changes. Survey of Ophthalmology 2017;62:286-301. [DOI: 10.1016/j.survophthal.2016.11.008] [Cited by in Crossref: 49] [Cited by in F6Publishing: 42] [Article Influence: 9.8] [Reference Citation Analysis]
80 Zhou L, Geraci G, Hess S, Yang L, Wang J, Argikar U. Predicting Phospholipidosis: A Fluorescence Noncell Based in Vitro Assay for the Determination of Drug–Phospholipid Complex Formation in Early Drug Discovery. Anal Chem 2011;83:6980-7. [DOI: 10.1021/ac200683k] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
81 Sadler R; School of Medicine and Centre for Environment and Population Health, Griffith University, Gold Coast Campus, Parklands Drive, Southport QLD, 4215, Australia. . AIMS Environmental Science 2015;2:827-51. [DOI: 10.3934/environsci.2015.3.827] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
82 Varalda M, Antona A, Bettio V, Roy K, Vachamaram A, Yellenki V, Massarotti A, Baldanzi G, Capello D. Psychotropic Drugs Show Anticancer Activity by Disrupting Mitochondrial and Lysosomal Function. Front Oncol 2020;10:562196. [PMID: 33194631 DOI: 10.3389/fonc.2020.562196] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
83 Bessone F, Dirchwolf M, Rodil MA, Razori MV, Roma MG. Review article: drug-induced liver injury in the context of nonalcoholic fatty liver disease - a physiopathological and clinical integrated view. Aliment Pharmacol Ther 2018;48:892-913. [PMID: 30194708 DOI: 10.1111/apt.14952] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 8.5] [Reference Citation Analysis]
84 Zhou Y, Li S, Mäyränpää MI, Zhong W, Bäck N, Yan D, Olkkonen VM. OSBP-related protein 11 (ORP11) dimerizes with ORP9 and localizes at the Golgi–late endosome interface. Experimental Cell Research 2010;316:3304-16. [DOI: 10.1016/j.yexcr.2010.06.008] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 1.8] [Reference Citation Analysis]
85 Zhao X, Chen W, Liu Z, Guo J, Zhou Z, Crommen J, Moaddel R, Jiang Z. A novel mixed phospholipid functionalized monolithic column for early screening of drug induced phospholipidosis risk. Journal of Chromatography A 2014;1367:99-108. [DOI: 10.1016/j.chroma.2014.09.048] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
86 Yudate HT, Kai T, Aoki M, Minowa Y, Yamada T, Kimura T, Ono A, Yamada H, Ohno Y, Urushidani T. Identification of a novel set of biomarkers for evaluating phospholipidosis-inducing potential of compounds using rat liver microarray data measured 24-h after single dose administration. Toxicology 2012;295:1-7. [DOI: 10.1016/j.tox.2012.02.015] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
87 Schmitz G, Grandl M. Endolysosomal phospholipidosis and cytosolic lipid droplet storage and release in macrophages. Biochim Biophys Acta 2009;1791:524-39. [PMID: 19146988 DOI: 10.1016/j.bbalip.2008.12.007] [Cited by in Crossref: 38] [Cited by in F6Publishing: 35] [Article Influence: 2.7] [Reference Citation Analysis]
88 Pagliarusco S, Martinucci S, Bordini E, Miraglia L, Cufari D, Ferrari L, Pellegatti M. Tissue Distribution and Characterization of Drug-Related Material in Rats and Dogs after Repeated Oral Administration of Casopitant. Drug Metab Dispos 2011;39:283-93. [DOI: 10.1124/dmd.110.035063] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
89 Grabner GF, Fawzy N, Pribasnig MA, Trieb M, Taschler U, Holzer M, Schweiger M, Wolinski H, Kolb D, Horvath A, Breinbauer R, Rülicke T, Rabl R, Lass A, Stadlbauer V, Hutter-Paier B, Stauber RE, Fickert P, Zechner R, Marsche G, Eichmann TO, Zimmermann R. Metabolic disease and ABHD6 alter the circulating bis(monoacylglycerol)phosphate profile in mice and humans. J Lipid Res 2019;60:1020-31. [PMID: 30894461 DOI: 10.1194/jlr.M093351] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 3.3] [Reference Citation Analysis]
90 Nujić K, Banjanac M, Munić V, Polančec D, Eraković Haber V. Impairment of lysosomal functions by azithromycin and chloroquine contributes to anti-inflammatory phenotype. Cell Immunol 2012;279:78-86. [PMID: 23099154 DOI: 10.1016/j.cellimm.2012.09.007] [Cited by in Crossref: 40] [Cited by in F6Publishing: 39] [Article Influence: 4.0] [Reference Citation Analysis]
91 Pospischil A, Walther P, Dingemanse J. Phospholipidosis in healthy subjects participating in clinical studies: Ultrastructural findings in white blood cells. Experimental and Toxicologic Pathology 2010;62:567-71. [DOI: 10.1016/j.etp.2009.07.007] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
92 Vejux A, Guyot S, Montange T, Riedinger J, Kahn E, Lizard G. Phospholipidosis and down-regulation of the PI3-K/PDK-1/Akt signalling pathway are vitamin E inhibitable events associated with 7-ketocholesterol-induced apoptosis. The Journal of Nutritional Biochemistry 2009;20:45-61. [DOI: 10.1016/j.jnutbio.2007.12.001] [Cited by in Crossref: 71] [Cited by in F6Publishing: 68] [Article Influence: 5.5] [Reference Citation Analysis]
93 Egbelowo O, Sarathy JP, Gausi K, Zimmerman MD, Wang H, Wijnant GJ, Kaya F, Gengenbacher M, Van N, Degefu Y, Nacy C, Aldridge BB, Carter CL, Denti P, Dartois V. Pharmacokinetics and Target Attainment of SQ109 in Plasma and Human-Like Tuberculosis Lesions in Rabbits. Antimicrob Agents Chemother 2021;65:e0002421. [PMID: 34228540 DOI: 10.1128/AAC.00024-21] [Reference Citation Analysis]
94 Almela MJ, Torres PA, Lozano S, Herreros E. Characterization of the phospholipidogenic potential of 4(1H)-pyridone antimalarial derivatives. Toxicol In Vitro 2009;23:1528-34. [PMID: 19540329 DOI: 10.1016/j.tiv.2009.06.015] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
95 Mrakovcic M, Absenger M, Riedl R, Smole C, Roblegg E, Fröhlich LF, Fröhlich E. Assessment of long-term effects of nanoparticles in a microcarrier cell culture system. PLoS One 2013;8:e56791. [PMID: 23457616 DOI: 10.1371/journal.pone.0056791] [Cited by in Crossref: 38] [Cited by in F6Publishing: 32] [Article Influence: 4.2] [Reference Citation Analysis]
96 Gonzalez-suarez I, Martin F, Hoeng J, Peitsch MC. Mechanistic Network Models in Safety and Toxicity Evaluation of Nutraceuticals. Nutraceuticals. Elsevier; 2016. pp. 287-304. [DOI: 10.1016/b978-0-12-802147-7.00022-x] [Cited by in Crossref: 4] [Article Influence: 0.7] [Reference Citation Analysis]
97 Appelqvist H, Sandin L, Björnström K, Saftig P, Garner B, Ollinger K, Kågedal K. Sensitivity to lysosome-dependent cell death is directly regulated by lysosomal cholesterol content. PLoS One 2012;7:e50262. [PMID: 23166840 DOI: 10.1371/journal.pone.0050262] [Cited by in Crossref: 49] [Cited by in F6Publishing: 50] [Article Influence: 4.9] [Reference Citation Analysis]
98 Passarelli MK, Pirkl A, Moellers R, Grinfeld D, Kollmer F, Havelund R, Newman CF, Marshall PS, Arlinghaus H, Alexander MR, West A, Horning S, Niehuis E, Makarov A, Dollery CT, Gilmore IS. The 3D OrbiSIMS—label-free metabolic imaging with subcellular lateral resolution and high mass-resolving power. Nat Methods 2017;14:1175-83. [DOI: 10.1038/nmeth.4504] [Cited by in Crossref: 174] [Cited by in F6Publishing: 129] [Article Influence: 34.8] [Reference Citation Analysis]
99 Sakurai T, Kamio K, Sasaki K, Nishimoto T, Yamaguchi JI, Sasaki M, Tsutsumi S. Imaging Mass Microscopy of Kidneys from Azithromycin-Treated Rats with Phospholipidosis. Am J Pathol 2018;188:1993-2003. [PMID: 29981744 DOI: 10.1016/j.ajpath.2018.05.018] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
100 Hoffman E, Murnane D, Hutter V. Investigating the Suitability of High Content Image Analysis as a Tool to Assess the Reversibility of Foamy Alveolar Macrophage Phenotypes In Vitro. Pharmaceutics 2020;12:E262. [PMID: 32183061 DOI: 10.3390/pharmaceutics12030262] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
101 van de Water F, Havinga J, Ravesloot W, Horbach G, Schoonen W. High content screening analysis of phospholipidosis: Validation of a 96-well assay with CHO-K1 and HepG2 cells for the prediction of in vivo based phospholipidosis. Toxicology in Vitro 2011;25:1870-82. [DOI: 10.1016/j.tiv.2011.05.026] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 2.7] [Reference Citation Analysis]
102 King A, Baginski M, Morikawa Y, Rainville PD, Gethings LA, Wilson ID, Plumb RS. Application of a Novel Mass Spectral Data Acquisition Approach to Lipidomic Analysis of Liver Extracts from Sitaxentan-Treated Liver-Humanized PXB Mice. J Proteome Res 2019;18:4055-64. [DOI: 10.1021/acs.jproteome.9b00334] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
103 Solhaug A, Torgersen ML, Holme JA, Lagadic-Gossmann D, Eriksen GS. Autophagy and senescence, stress responses induced by the DNA-damaging mycotoxin alternariol. Toxicology 2014;326:119-29. [PMID: 25456271 DOI: 10.1016/j.tox.2014.10.009] [Cited by in Crossref: 28] [Cited by in F6Publishing: 31] [Article Influence: 3.5] [Reference Citation Analysis]
104 Canfrán-Duque A, Pastor Ó, García-Seisdedos D, Molina YL, Babiy B, Lerma M, Sánchez-Castellano C, Martínez-Botas J, Gómez-Coronado D, Lasunción MA, Cruz-Jentoft AJ, Busto R. The Antipsychotic Risperidone Alters Dihydroceramide and Ceramide Composition and Plasma Membrane Function in Leukocytes In Vitro and In Vivo. Int J Mol Sci 2021;22:3919. [PMID: 33920193 DOI: 10.3390/ijms22083919] [Reference Citation Analysis]
105 Glock M, Muehlbacher M, Hurtig H, Tripal P, Kornhuber J. Drug-induced phospholipidosis caused by combinations of common drugs in vitro. Toxicology in Vitro 2016;35:139-48. [DOI: 10.1016/j.tiv.2016.05.010] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
106 Ceccarelli M, Wagner B, Alvarez-sánchez R, Cruciani G, Goracci L. Use of the Distribution Coefficient in Brain Polar Lipids for the Assessment of Drug-Induced Phospholipidosis Risk. Chem Res Toxicol 2017;30:1145-56. [DOI: 10.1021/acs.chemrestox.6b00459] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
107 Murcar-evans BI, Cabral AD, Toutah K, de Araujo ED, Lai A, Macdonald PM, Berger-becvar A, Kraskouskaya D, Gunning PT. ProxyPhos sensors for the detection of negatively charged membranes. Analyst 2017;142:4511-21. [DOI: 10.1039/c7an00568g] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
108 Jiang Z, Reilly J. Chromatography approaches for early screening of the phospholipidosis-inducing potential of pharmaceuticals. Journal of Pharmaceutical and Biomedical Analysis 2012;61:184-90. [DOI: 10.1016/j.jpba.2011.11.033] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
109 Liu Y, Kam WR, Ding J, Sullivan DA. One man's poison is another man's meat: using azithromycin-induced phospholipidosis to promote ocular surface health. Toxicology 2014;320:1-5. [PMID: 24613571 DOI: 10.1016/j.tox.2014.02.014] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 4.8] [Reference Citation Analysis]
110 Schulze H, Kolter T, Sandhoff K. Principles of lysosomal membrane degradation: Cellular topology and biochemistry of lysosomal lipid degradation. Biochim Biophys Acta 2009;1793:674-83. [PMID: 19014978 DOI: 10.1016/j.bbamcr.2008.09.020] [Cited by in Crossref: 154] [Cited by in F6Publishing: 150] [Article Influence: 11.0] [Reference Citation Analysis]
111 Chan KLA, Lekkas I, Frogley MD, Cinque G, Altharawi A, Bello G, Dailey LA. Synchrotron Photothermal Infrared Nanospectroscopy of Drug-Induced Phospholipidosis in Macrophages. Anal Chem 2020;92:8097-107. [PMID: 32396367 DOI: 10.1021/acs.analchem.9b05759] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
112 Filippone EJ, Carson JM, Beckford RA, Jaffe BC, Newman E, Awsare BK, Doria C, Farber JL. Sirolimus-induced pneumonitis complicated by pentamidine-induced phospholipidosis in a renal transplant recipient: a case report. Transplant Proc 2011;43:2792-7. [PMID: 21911165 DOI: 10.1016/j.transproceed.2011.06.060] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
113 Lecommandeur E, Baker D, Cox TM, Nicholls AW, Griffin JL. Alterations in endo-lysosomal function induce similar hepatic lipid profiles in rodent models of drug-induced phospholipidosis and Sandhoff disease. J Lipid Res 2017;58:1306-14. [PMID: 28377426 DOI: 10.1194/jlr.M073395] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
114 Shi Q, Hong H, Senior J, Tong W. Biomarkers for drug-induced liver injury. Expert Review of Gastroenterology & Hepatology 2014;4:225-34. [DOI: 10.1586/egh.10.8] [Cited by in Crossref: 60] [Cited by in F6Publishing: 55] [Article Influence: 7.5] [Reference Citation Analysis]
115 Danielsen EM, Hansen GH, Severinsen MC. Okadaic acid: A rapid inducer of lamellar bodies in small intestinal enterocytes. Toxicon 2014;88:77-87. [DOI: 10.1016/j.toxicon.2014.06.011] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
116 Lee AY, St Onge RP, Proctor MJ, Wallace IM, Nile AH, Spagnuolo PA, Jitkova Y, Gronda M, Wu Y, Kim MK, Cheung-Ong K, Torres NP, Spear ED, Han MK, Schlecht U, Suresh S, Duby G, Heisler LE, Surendra A, Fung E, Urbanus ML, Gebbia M, Lissina E, Miranda M, Chiang JH, Aparicio AM, Zeghouf M, Davis RW, Cherfils J, Boutry M, Kaiser CA, Cummins CL, Trimble WS, Brown GW, Schimmer AD, Bankaitis VA, Nislow C, Bader GD, Giaever G. Mapping the cellular response to small molecules using chemogenomic fitness signatures. Science 2014;344:208-11. [PMID: 24723613 DOI: 10.1126/science.1250217] [Cited by in Crossref: 171] [Cited by in F6Publishing: 145] [Article Influence: 21.4] [Reference Citation Analysis]
117 Deidda A, Pisanu C, Micheletto L, Bocchetta A, Del Zompo M, Stochino ME. Interstitial lung disease induced by fluoxetine: Systematic review of literature and analysis of Vigiaccess, Eudravigilance and a national pharmacovigilance database. Pharmacological Research 2017;120:294-301. [DOI: 10.1016/j.phrs.2017.04.010] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
118 Greeley MA. Immunopathology of the Respiratory System. In: Parker GA, editor. Immunopathology in Toxicology and Drug Development. Cham: Springer International Publishing; 2017. pp. 419-53. [DOI: 10.1007/978-3-319-47385-7_8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
119 Morissette G, Lodge R, Marceau F. Intense pseudotransport of a cationic drug mediated by vacuolar ATPase: Procainamide-induced autophagic cell vacuolization. Toxicology and Applied Pharmacology 2008;228:364-77. [DOI: 10.1016/j.taap.2007.12.031] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 2.1] [Reference Citation Analysis]
120 Ellison CM, Enoch SJ, Cronin MT. A review of the use of in silico methods to predict the chemistry of molecular initiating events related to drug toxicity. Expert Opinion on Drug Metabolism & Toxicology 2011;7:1481-95. [DOI: 10.1517/17425255.2011.629186] [Cited by in Crossref: 27] [Cited by in F6Publishing: 20] [Article Influence: 2.5] [Reference Citation Analysis]
121 Brahmi F, Vejux A, Sghaier R, Zarrouk A, Nury T, Meddeb W, Rezig L, Namsi A, Sassi K, Yammine A, Badreddine I, Vervandier-fasseur D, Madani K, Boulekbache-makhlouf L, Nasser B, Lizard G. Prevention of 7-ketocholesterol-induced side effects by natural compounds. Critical Reviews in Food Science and Nutrition 2019;59:3179-98. [DOI: 10.1080/10408398.2018.1491828] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
122 Bell CC, Lauschke VM, Vorrink SU, Palmgren H, Duffin R, Andersson TB, Ingelman-Sundberg M. Transcriptional, Functional, and Mechanistic Comparisons of Stem Cell-Derived Hepatocytes, HepaRG Cells, and Three-Dimensional Human Hepatocyte Spheroids as Predictive In Vitro Systems for Drug-Induced Liver Injury. Drug Metab Dispos 2017;45:419-29. [PMID: 28137721 DOI: 10.1124/dmd.116.074369] [Cited by in Crossref: 96] [Cited by in F6Publishing: 83] [Article Influence: 19.2] [Reference Citation Analysis]
123 Papiris SA, Triantafillidou C, Kolilekas L, Markoulaki D, Manali ED. Amiodarone: Review of Pulmonary Effects and Toxicity. Drug Safety 2010;33:539-58. [DOI: 10.2165/11532320-000000000-00000] [Cited by in Crossref: 113] [Cited by in F6Publishing: 85] [Article Influence: 9.4] [Reference Citation Analysis]
124 Janardhan S, John L, Prasanthi M, Poroikov V, Narahari Sastry G. A QSAR and molecular modelling study towards new lead finding: polypharmacological approach to Mycobacterium tuberculosis. SAR QSAR Environ Res 2017;28:815-32. [PMID: 29183232 DOI: 10.1080/1062936X.2017.1398782] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
125 Slavov SH, Wilkes JG, Buzatu DA, Kruhlak NL, Willard JM, Hanig JP, Beger RD. Computational identification of a phospholipidosis toxicophore using 13 C and 15 N NMR-distance based fingerprints. Bioorganic & Medicinal Chemistry 2014;22:6706-14. [DOI: 10.1016/j.bmc.2014.08.021] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
126 Dugas B, Charbonnier S, Baarine M, Ragot K, Delmas D, Ménétrier F, Lherminier J, Malvitte L, Khalfaoui T, Bron A, Creuzot-Garcher C, Latruffe N, Lizard G. Effects of oxysterols on cell viability, inflammatory cytokines, VEGF, and reactive oxygen species production on human retinal cells: cytoprotective effects and prevention of VEGF secretion by resveratrol. Eur J Nutr 2010;49:435-46. [PMID: 20339855 DOI: 10.1007/s00394-010-0102-2] [Cited by in Crossref: 71] [Cited by in F6Publishing: 70] [Article Influence: 5.9] [Reference Citation Analysis]
127 Ibraheem AS, Seleem AA, El-sayed MF, Hamad BH. Single or combined cadmium and aluminum intoxication of mice liver and kidney with possible effect of zinc. The Journal of Basic & Applied Zoology 2016;77:91-101. [DOI: 10.1016/j.jobaz.2016.12.004] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
128 Matuszyk E, Adamczyk A, Radwan B, Pieczara A, Szcześniak P, Mlynarski J, Kamińska K, Baranska M. Multiplex Raman imaging of organelles in endothelial cells. Spectrochim Acta A Mol Biomol Spectrosc 2021;255:119658. [PMID: 33744837 DOI: 10.1016/j.saa.2021.119658] [Reference Citation Analysis]
129 Armstrong D, Li S, Frieauff W, Martus H, Reilly J, Mikhailov D, Whitebread S, Urban L. Predictive Toxicology: Latest Scientific Developments and Their Application in Safety Assessment. Comprehensive Medicinal Chemistry III. Elsevier; 2017. pp. 94-115. [DOI: 10.1016/b978-0-12-409547-2.12367-4] [Cited by in Crossref: 2] [Article Influence: 0.4] [Reference Citation Analysis]
130 Ramm S, Todorov P, Chandrasekaran V, Dohlman A, Monteiro MB, Pavkovic M, Muhlich J, Shankaran H, Chen WW, Mettetal JT, Vaidya VS. A Systems Toxicology Approach for the Prediction of Kidney Toxicity and Its Mechanisms In Vitro. Toxicol Sci 2019;169:54-69. [PMID: 30649541 DOI: 10.1093/toxsci/kfz021] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
131 Liu N, Tengstrand EA, Chourb L, Hsieh FY. Di-22:6-bis(monoacylglycerol)phosphate: A clinical biomarker of drug-induced phospholipidosis for drug development and safety assessment. Toxicol Appl Pharmacol 2014;279:467-76. [PMID: 24967688 DOI: 10.1016/j.taap.2014.06.014] [Cited by in Crossref: 45] [Cited by in F6Publishing: 39] [Article Influence: 5.6] [Reference Citation Analysis]
132 Alakoskela JM, Vitovic P, Kinnunen PK. Screening for the drug-phospholipid interaction: correlation to phospholipidosis. ChemMedChem 2009;4:1224-51. [PMID: 19551800 DOI: 10.1002/cmdc.200900052] [Cited by in Crossref: 41] [Cited by in F6Publishing: 34] [Article Influence: 3.2] [Reference Citation Analysis]
133 Logan R, Kong AC, Krise JP. Time-dependent effects of hydrophobic amine-containing drugs on lysosome structure and biogenesis in cultured human fibroblasts. J Pharm Sci 2014;103:3287-96. [PMID: 25042198 DOI: 10.1002/jps.24087] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 2.6] [Reference Citation Analysis]
134 Begriche K, Massart J, Robin MA, Borgne-Sanchez A, Fromenty B. Drug-induced toxicity on mitochondria and lipid metabolism: mechanistic diversity and deleterious consequences for the liver. J Hepatol. 2011;54:773-794. [PMID: 21145849 DOI: 10.1016/j.jhep.2010.11.006] [Cited by in Crossref: 308] [Cited by in F6Publishing: 278] [Article Influence: 25.7] [Reference Citation Analysis]
135 Kiselyov K, Yamaguchi S, Lyons CW, Muallem S. Aberrant Ca2+ handling in lysosomal storage disorders. Cell Calcium 2010;47:103-11. [PMID: 20053447 DOI: 10.1016/j.ceca.2009.12.007] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 3.0] [Reference Citation Analysis]
136 Roman DL, Roman M, Som C, Schmutz M, Hernandez E, Wick P, Casalini T, Perale G, Ostafe V, Isvoran A. Computational Assessment of the Pharmacological Profiles of Degradation Products of Chitosan. Front Bioeng Biotechnol 2019;7:214. [PMID: 31552240 DOI: 10.3389/fbioe.2019.00214] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
137 Zhang X, Yang L, Liu Y, Song Z, Zhao J, Chen D, Yu H, Li R, Wang Y, Yang K, Chen Y, Xia M, Zhang LW. Detection of nanocarrier potentiation on drug induced phospholipidosis in cultured cells and primary hepatocyte spheroids by high content imaging and analysis. Toxicol Appl Pharmacol 2018;348:54-66. [PMID: 29678448 DOI: 10.1016/j.taap.2018.04.016] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
138 Celanire S, Lebon F, Stark H. Drug Discovery. In: Vohora D, editor. The Third Histamine Receptor. CRC Press; 2008. pp. 103-65. [DOI: 10.1201/9781420053937.ch5] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
139 Bocchini N, Giantin M, Crivellente F, Ferraresso S, Faustinelli I, Dacasto M, Cristofori P. Molecular biomarkers of phospholipidosis in rat blood and heart after amiodarone treatment: Biomarkers of phospholipidosis in rat blood and heart. J Appl Toxicol 2015;35:90-103. [DOI: 10.1002/jat.2992] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
140 Chen VY, Posada MM, Zhao L, Rosania GR. Rapid doxorubicin efflux from the nucleus of drug-resistant cancer cells following extracellular drug clearance. Pharm Res 2007;24:2156-67. [PMID: 17668300 DOI: 10.1007/s11095-007-9369-2] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 0.9] [Reference Citation Analysis]
141 LaLone V, Mourão MA, Standiford TJ, Raghavendran K, Shedden K, Stringer KA, Rosania GR. An Expandable Mechanopharmaceutical Device (3): a Versatile Raman Spectral Cytometry Approach to Study the Drug Cargo Capacity of Individual Macrophages. Pharm Res 2018;36:2. [PMID: 30402713 DOI: 10.1007/s11095-018-2540-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
142 Liu Y, Kam WR, Fernandes P, Sullivan DA. The Effect of Solithromycin, a Cationic Amphiphilic Drug, on the Proliferation and Differentiation of Human Meibomian Gland Epithelial Cells. Curr Eye Res 2018;43:683-8. [PMID: 29283676 DOI: 10.1080/02713683.2017.1418894] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
143 Hermansson M, Hokynar K, Somerharju P. Mechanisms of glycerophospholipid homeostasis in mammalian cells. Progress in Lipid Research 2011;50:240-57. [DOI: 10.1016/j.plipres.2011.02.004] [Cited by in Crossref: 116] [Cited by in F6Publishing: 112] [Article Influence: 10.5] [Reference Citation Analysis]
144 Stern ST, McNeil SE. Nanotechnology safety concerns revisited. Toxicol Sci 2008;101:4-21. [PMID: 17602205 DOI: 10.1093/toxsci/kfm169] [Cited by in Crossref: 359] [Cited by in F6Publishing: 289] [Article Influence: 23.9] [Reference Citation Analysis]
145 Jiang H, Passarelli MK, Munro PM, Kilburn MR, West A, Dollery CT, Gilmore IS, Rakowska PD. High-resolution sub-cellular imaging by correlative NanoSIMS and electron microscopy of amiodarone internalisation by lung macrophages as evidence for drug-induced phospholipidosis. Chem Commun (Camb) 2017;53:1506-9. [PMID: 28085162 DOI: 10.1039/c6cc08549k] [Cited by in Crossref: 29] [Cited by in F6Publishing: 8] [Article Influence: 7.3] [Reference Citation Analysis]
146 Logan R, Kong AC, Axcell E, Krise JP. Amine-Containing Molecules and the Induction of an Expanded Lysosomal Volume Phenotype: A Structure–Activity Relationship Study. Journal of Pharmaceutical Sciences 2014;103:1572-80. [DOI: 10.1002/jps.23949] [Cited by in Crossref: 27] [Cited by in F6Publishing: 20] [Article Influence: 3.4] [Reference Citation Analysis]
147 Vitovič P, Alakoskela J, Kinnunen PKJ. Assessment of Drug−Lipid Complex Formation by a High-Throughput Langmuir-Balance and Correlation to Phospholipidosis. J Med Chem 2008;51:1842-8. [DOI: 10.1021/jm7013953] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 2.6] [Reference Citation Analysis]
148 Buratta S, Urbanelli L, Ferrara G, Sagini K, Goracci L, Emiliani C. A role for the autophagy regulator Transcription Factor EB in amiodarone-induced phospholipidosis. Biochemical Pharmacology 2015;95:201-9. [DOI: 10.1016/j.bcp.2015.03.017] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
149 Garenc C, Julien P, Levy E. Oxysterols in biological systems: The gastrointestinal tract, liver, vascular wall and central nervous system. Free Radical Research 2009;44:47-73. [DOI: 10.3109/10715760903321804] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 2.4] [Reference Citation Analysis]
150 Stark M, Silva TFD, Levin G, Machuqueiro M, Assaraf YG. The Lysosomotropic Activity of Hydrophobic Weak Base Drugs is Mediated via Their Intercalation into the Lysosomal Membrane. Cells 2020;9:E1082. [PMID: 32349204 DOI: 10.3390/cells9051082] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 6.5] [Reference Citation Analysis]
151 Kassai M, Teopipithaporn R, Grant KB. Hydrolysis of phosphatidylcholine by cerium(IV) releases significant amounts of choline and inorganic phosphate at lysosomal pH. J Inorg Biochem 2011;105:215-23. [PMID: 21194621 DOI: 10.1016/j.jinorgbio.2010.11.007] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
152 Goldman SD, Funk RS, Rajewski RA, Krise JP. Mechanisms of amine accumulation in, and egress from, lysosomes. Bioanalysis 2009;1:1445-59. [PMID: 21083094 DOI: 10.4155/bio.09.128] [Cited by in Crossref: 62] [Cited by in F6Publishing: 61] [Article Influence: 5.6] [Reference Citation Analysis]
153 Saito K, Maekawa K, Ishikawa M, Senoo Y, Urata M, Murayama M, Nakatsu N, Yamada H, Saito Y. Glucosylceramide and lysophosphatidylcholines as potential blood biomarkers for drug-induced hepatic phospholipidosis. Toxicol Sci 2014;141:377-86. [PMID: 24980264 DOI: 10.1093/toxsci/kfu132] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.4] [Reference Citation Analysis]
154 Barone LR, Boyer S, Damewood JR Jr, Fikes J, Ciaccio PJ. Phospholipogenic pharmaceuticals are associated with a higher incidence of histological findings than nonphospholipogenic pharmaceuticals in preclinical toxicology studies. J Toxicol 2012;2012:308594. [PMID: 22745636 DOI: 10.1155/2012/308594] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
155 Orogo AM, Choi SS, Minnier BL, Kruhlak NL. Construction and Consensus Performance of (Q)SAR Models for Predicting Phospholipidosis Using a Dataset of 743 Compounds. Mol Inf 2012;31:725-39. [DOI: 10.1002/minf.201200048] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 2.7] [Reference Citation Analysis]
156 Ettlin RA, Kuroda J, Plassmann S, Prentice DE. Successful drug development despite adverse preclinical findings part 1: processes to address issues and most important findings. J Toxicol Pathol 2010;23:189-211. [PMID: 22272031 DOI: 10.1293/tox.23.189] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
157 Romão RI, Maçôas E, Martinho JM, Gonçalves da Silva AM. Interaction of toremifene with dipalmitoyl-phosphatidyl-glycerol in monolayers at the air–water interface followed by fluorescence microscopy in Langmuir–Blodgett films. Thin Solid Films 2013;534:584-90. [DOI: 10.1016/j.tsf.2013.02.052] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
158 Zhen H, Teng Q, Mosley JD, Collette TW, Yue Y, Bradley PM, Ekman DR. Untargeted Lipidomics for Determining Cellular and Subcellular Responses in Zebrafish (Danio rerio) Liver Cells Following Exposure to Complex Mixtures in U.S. Streams. Environ Sci Technol 2021;55:8180-90. [PMID: 34096267 DOI: 10.1021/acs.est.1c01132] [Reference Citation Analysis]
159 Faure C, Paques M, Audo I. Electrophysiological features and multimodal imaging in ritonavir-related maculopathy. Doc Ophthalmol 2017;135:241-8. [PMID: 28900746 DOI: 10.1007/s10633-017-9612-z] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 2.2] [Reference Citation Analysis]
160 Jennings P, Schwarz M, Landesmann B, Maggioni S, Goumenou M, Bower D, Leonard MO, Wiseman JS. SEURAT-1 liver gold reference compounds: a mechanism-based review. Arch Toxicol 2014;88:2099-133. [DOI: 10.1007/s00204-014-1410-8] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
161 de Tezanos Pinto F, Adamo HP. The strategic function of the P5-ATPase ATP13A2 in toxic waste disposal. Neurochemistry International 2018;112:108-13. [DOI: 10.1016/j.neuint.2017.11.008] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
162 Kohonen P, Benfenati E, Bower D, Ceder R, Crump M, Cross K, Grafström RC, Healy L, Helma C, Jeliazkova N, Jeliazkov V, Maggioni S, Miller S, Myatt G, Rautenberg M, Stacey G, Willighagen E, Wiseman J, Hardy B. The ToxBank Data Warehouse: Supporting the Replacement of In Vivo Repeated Dose Systemic Toxicity Testing. Mol Inform 2013;32:47-63. [PMID: 27481023 DOI: 10.1002/minf.201200114] [Cited by in Crossref: 26] [Cited by in F6Publishing: 19] [Article Influence: 2.9] [Reference Citation Analysis]
163 Hinkovska-Galcheva V, Treadwell T, Shillingford JM, Lee A, Abe A, Tesmer JJG, Shayman JA. Inhibition of lysosomal phospholipase A2 predicts drug-induced phospholipidosis. J Lipid Res 2021;62:100089. [PMID: 34087196 DOI: 10.1016/j.jlr.2021.100089] [Reference Citation Analysis]
164 Sardi-segovia L, Rocher A, Pugliese M, Chenlo P, Curi S, Ariagno J, Repetto H, Cohen M, Mendeluk G, Palaoro L. Prognostic value of germ cells in the ejaculate: a case study. Biotechnic & Histochemistry 2010;86:232-41. [DOI: 10.3109/10520291003694452] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
165 Nioi P, Pardo ID, Snyder RD. Monitoring the accumulation of fluorescently labeled phospholipids in cell cultures provides an accurate screen for drugs that induce phospholipidosis. Drug Chem Toxicol 2008;31:515-28. [PMID: 18850360 DOI: 10.1080/01480540802391229] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
166 Lewis JH, Kleiner DE. Hepatic injury due to drugs, herbal compounds, chemicals and toxins. MacSween's Pathology of the Liver. Elsevier; 2012. pp. 645-760. [DOI: 10.1016/b978-0-7020-3398-8.00013-1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 1] [Article Influence: 1.1] [Reference Citation Analysis]
167 Elmore SA, Farman CA, Hailey JR, Kovi RC, Malarkey DE, Morrison JP, Neel J, Pesavento PA, Porter BF, Szabo KA, Teixeira LB, Quist EM. Proceedings of the 2015 National Toxicology Program Satellite Symposium. Toxicol Pathol 2016;44:502-35. [PMID: 27075180 DOI: 10.1177/0192623316631844] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
168 Hutchinson TH, Mahshid Y, Jönsson R, Björklund C, Kenne K. Proteomic analysis of phospholipidosis in citalopram treated U937 cells--support for the cholesterol biosynthesis hypothesis. Toxicol In Vitro 2008;22:1198-204. [PMID: 18499393 DOI: 10.1016/j.tiv.2008.03.016] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
169 Breiden B, Sandhoff K. Emerging mechanisms of drug-induced phospholipidosis. Biological Chemistry 2019;401:31-46. [DOI: 10.1515/hsz-2019-0270] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 9.7] [Reference Citation Analysis]
170 Coleman J, Xiang Y, Pande P, Shen D, Gatica D, Patton WF. A live-cell fluorescence microplate assay suitable for monitoring vacuolation arising from drug or toxic agent treatment. J Biomol Screen 2010;15:398-405. [PMID: 20237207 DOI: 10.1177/1087057110364242] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
171 Biczo G, Vegh ET, Shalbueva N, Mareninova OA, Elperin J, Lotshaw E, Gretler S, Lugea A, Malla SR, Dawson D, Ruchala P, Whitelegge J, French SW, Wen L, Husain SZ, Gorelick FS, Hegyi P, Rakonczay Z Jr, Gukovsky I, Gukovskaya AS. Mitochondrial Dysfunction, Through Impaired Autophagy, Leads to Endoplasmic Reticulum Stress, Deregulated Lipid Metabolism, and Pancreatitis in Animal Models. Gastroenterology. 2018;154:689-703. [PMID: 29074451 DOI: 10.1053/j.gastro.2017.10.012] [Cited by in Crossref: 93] [Cited by in F6Publishing: 85] [Article Influence: 18.6] [Reference Citation Analysis]
172 Öhlinger K, Absenger-Novak M, Meindl C, Ober J, Fröhlich E. Different Sensitivity of Macrophages to Phospholipidosis Induction by Amphiphilic Cationic Drugs. Int J Mol Sci 2020;21:E8391. [PMID: 33182310 DOI: 10.3390/ijms21218391] [Reference Citation Analysis]
173 Fried KW, Schneider CM, Schramm KW, Datta A, Chahbane N, Corsten C, Powell DR, Lenoir D, Kettrup A, Terranova P, Georg GI, Rozman KK. From dioxin to drug lead--the development of 2,3,7,8-tetrachlorophenothiazine. ChemMedChem 2007;2:890-7. [PMID: 17394264 DOI: 10.1002/cmdc.200700005] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
174 Stern ST, Adiseshaiah PP, Crist RM. Autophagy and lysosomal dysfunction as emerging mechanisms of nanomaterial toxicity. Part Fibre Toxicol 2012;9:20. [PMID: 22697169 DOI: 10.1186/1743-8977-9-20] [Cited by in Crossref: 487] [Cited by in F6Publishing: 456] [Article Influence: 48.7] [Reference Citation Analysis]
175 Shirai N, Geoly FJ, Bobrowski WF, Okerberg C. The Application of Paraphenylenediamine Staining for Assessment of Phospholipidosis. Toxicol Pathol 2016;44:1160-5. [DOI: 10.1177/0192623316673921] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
176 Luchetti F, Canonico B, Cesarini E, Betti M, Galluzzi L, Galli L, Tippins J, Zerbinati C, Papa S, Iuliano L. 7-Ketocholesterol and 5,6-secosterol induce human endothelial cell dysfunction by differential mechanisms. Steroids 2015;99:204-11. [PMID: 25697053 DOI: 10.1016/j.steroids.2015.02.008] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 4.1] [Reference Citation Analysis]
177 Solleti VS, Alhariri M, Halwani M, Omri A. Antimicrobial properties of liposomal azithromycin for Pseudomonas infections in cystic fibrosis patients. Journal of Antimicrobial Chemotherapy 2015;70:784-96. [DOI: 10.1093/jac/dku452] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 2.8] [Reference Citation Analysis]
178 Bell C, Skordilis K, Al-Baaj F, Bentall A. Imported bugs, not beasts: extensively drug-resistant tuberculosis and acute kidney injury. Clin Kidney J 2014;7:609-12. [PMID: 25859383 DOI: 10.1093/ckj/sfu102] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
179 Hroudová J, Fišar Z. In vitro inhibition of mitochondrial respiratory rate by antidepressants. Toxicol Lett. 2012;213:345-352. [PMID: 22842584 DOI: 10.1016/j.toxlet.2012.07.017] [Cited by in Crossref: 54] [Cited by in F6Publishing: 50] [Article Influence: 5.4] [Reference Citation Analysis]
180 Peropadre A, Fernández Freire P, Herrero Ó, Pérez Martín JM, Hazen MJ. Cellular Responses Associated with Dibucaine-Induced Phospholipidosis. Chem Res Toxicol 2011;24:185-92. [DOI: 10.1021/tx100262c] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
181 Sirci F, Napolitano F, Pisonero-Vaquero S, Carrella D, Medina DL, di Bernardo D. Comparing structural and transcriptional drug networks reveals signatures of drug activity and toxicity in transcriptional responses. NPJ Syst Biol Appl 2017;3:23. [PMID: 28861278 DOI: 10.1038/s41540-017-0022-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
182 Fröhlich E, Meindl C, Roblegg E, Ebner B, Absenger M, Pieber TR. Action of polystyrene nanoparticles of different sizes on lysosomal function and integrity. Part Fibre Toxicol 2012;9:26. [PMID: 22789069 DOI: 10.1186/1743-8977-9-26] [Cited by in Crossref: 61] [Cited by in F6Publishing: 60] [Article Influence: 6.1] [Reference Citation Analysis]
183 Mankikian J, Favelle O, Guillon A, Guilleminault L, Cormier B, Jonville-Béra AP, Perrotin D, Diot P, Marchand-Adam S. Initial characteristics and outcome of hospitalized patients with amiodarone pulmonary toxicity. Respir Med 2014;108:638-46. [PMID: 24565600 DOI: 10.1016/j.rmed.2014.01.014] [Cited by in Crossref: 16] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
184 Mennecozzi M, Landesmann B, Palosaari T, Harris G, Whelan M. Sex differences in liver toxicity-do female and male human primary hepatocytes react differently to toxicants in vitro? PLoS One 2015;10:e0122786. [PMID: 25849576 DOI: 10.1371/journal.pone.0122786] [Cited by in Crossref: 35] [Cited by in F6Publishing: 31] [Article Influence: 5.0] [Reference Citation Analysis]
185 Gorelik A, Gebai A, Illes K, Piomelli D, Nagar B. Molecular mechanism of activation of the immunoregulatory amidase NAAA. Proc Natl Acad Sci U S A 2018;115:E10032-40. [PMID: 30301806 DOI: 10.1073/pnas.1811759115] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
186 Barrett MJ, Shanker VL, Severt WL, Raymond D, Gross SJ, Schreiber-Agus N, Kornreich R, Ozelius LJ, Bressman SB, Saunders-Pullman R. Cognitive and Antipsychotic Medication Use in Monoallelic GBA-Related Parkinson Disease. JIMD Rep 2014;16:31-8. [PMID: 24850235 DOI: 10.1007/8904_2014_315] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
187 Balogh GT, Müller J, Könczöl A. pH-gradient PAMPA-based in vitro model assay for drug-induced phospholipidosis in early stage of drug discovery. Eur J Pharm Sci 2013;49:81-9. [PMID: 23439241 DOI: 10.1016/j.ejps.2013.02.005] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
188 Luciani P, Berti D, Fortini M, Baglioni P, Ghelardini C, Pacini A, Manetti D, Gualtieri F, Bartolini A, Di Cesare Mannelli L. Receptor-independent modulation of reconstituted Galpha(i) protein mediated by liposomes. Mol Biosyst 2009;5:356-67. [PMID: 19396372 DOI: 10.1039/b815042g] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
189 Kolter T. A view on sphingolipids and disease. Chem Phys Lipids. 2011;164:590-606. [PMID: 21570958 DOI: 10.1016/j.chemphyslip.2011.04.013] [Cited by in Crossref: 64] [Cited by in F6Publishing: 59] [Article Influence: 5.8] [Reference Citation Analysis]
190 Robbins N, Spitzer M, Yu T, Cerone RP, Averette AK, Bahn YS, Heitman J, Sheppard DC, Tyers M, Wright GD. An Antifungal Combination Matrix Identifies a Rich Pool of Adjuvant Molecules that Enhance Drug Activity against Diverse Fungal Pathogens. Cell Rep 2015;13:1481-92. [PMID: 26549450 DOI: 10.1016/j.celrep.2015.10.018] [Cited by in Crossref: 54] [Cited by in F6Publishing: 51] [Article Influence: 7.7] [Reference Citation Analysis]
191 Kruhlak NL, Choi SS, Contrera JF, Weaver JL, Willard JM, Hastings KL, Sancilio LF. Development of a Phospholipidosis Database and Predictive Quantitative Structure-Activity Relationship (QSAR) Models. Toxicology Mechanisms and Methods 2008;18:217-27. [DOI: 10.1080/15376510701857262] [Cited by in Crossref: 40] [Cited by in F6Publishing: 35] [Article Influence: 2.9] [Reference Citation Analysis]
192 Mella A, Messina M, Ranghino A, Solidoro P, Tabbia G, Segoloni GP, Biancone L. Pulmonary toxicity in a renal transplant recipient treated with amiodarone and everolimus: a case of hypothetical synergy and a proposal for a screening protocol. Case Rep Nephrol Urol 2014;4:75-81. [PMID: 24847349 DOI: 10.1159/000362361] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
193 Salata C, Calistri A, Parolin C, Baritussio A, Palù G. Antiviral activity of cationic amphiphilic drugs. Expert Rev Anti Infect Ther 2017;15:483-92. [PMID: 28286997 DOI: 10.1080/14787210.2017.1305888] [Cited by in Crossref: 69] [Cited by in F6Publishing: 64] [Article Influence: 13.8] [Reference Citation Analysis]
194 Maaetoft-Udsen K, Greineisen WE, Aldan JT, Magaoay H, Ligohr C, Shimoda LM, Sung C, Turner H. Comparative analysis of lipotoxicity induced by endocrine, pharmacological, and innate immune stimuli in rat basophilic leukemia cells. J Immunotoxicol 2015;12:385-94. [PMID: 25539471 DOI: 10.3109/1547691X.2014.990655] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
195 Perico ME, Crivellente F, Faustinelli I, Suozzi A, Cristofori P. Flow cytometry, with double staining with Nile red and anti-CD3 antibody, to detect phospholipidosis in peripheral blood lymphocytes of rats treated with amiodarone. Cell Biol Toxicol 2009;25:587-98. [PMID: 19105033 DOI: 10.1007/s10565-008-9114-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
196 Eich C, Manzo C, de Keijzer S, Bakker GJ, Reinieren-Beeren I, García-Parajo MF, Cambi A. Changes in membrane sphingolipid composition modulate dynamics and adhesion of integrin nanoclusters. Sci Rep 2016;6:20693. [PMID: 26869100 DOI: 10.1038/srep20693] [Cited by in Crossref: 38] [Cited by in F6Publishing: 33] [Article Influence: 6.3] [Reference Citation Analysis]
197 Anheuser S, Breiden B, Sandhoff K. Ganglioside GM2 catabolism is inhibited by storage compounds of mucopolysaccharidoses and by cationic amphiphilic drugs. Molecular Genetics and Metabolism 2019;128:75-83. [DOI: 10.1016/j.ymgme.2019.04.007] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
198 Min KA, Rajeswaran WG, Oldenbourg R, Harris G, Keswani RK, Chiang M, Rzeczycki P, Talattof A, Hafeez M, Horobin RW, Larsen SD, Stringer KA, Rosania GR. Massive Bioaccumulation and Self-Assembly of Phenazine Compounds in Live Cells. Adv Sci (Weinh) 2015;2:1500025. [PMID: 26380168 DOI: 10.1002/advs.201500025] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
199 Wusu AD, Sibuyi NRS, Moabelo KL, Goboza M, Madiehe A, Meyer M. Citrate-capped gold nanoparticles with a diameter of 14 nm alter the expression of genes associated with stress response, cytoprotection and lipid metabolism in CaCo-2 cells. Nanotechnology 2021;33. [PMID: 34814123 DOI: 10.1088/1361-6528/ac3c7c] [Reference Citation Analysis]
200 Allen TEH, Goodman JM, Gutsell S, Russell PJ. Defining Molecular Initiating Events in the Adverse Outcome Pathway Framework for Risk Assessment. Chem Res Toxicol 2014;27:2100-12. [DOI: 10.1021/tx500345j] [Cited by in Crossref: 89] [Cited by in F6Publishing: 77] [Article Influence: 11.1] [Reference Citation Analysis]